ClinicalTrials.govpublic full text
Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
bipolar disorders, metabolic complication, bipolar disorder, aripiprazole, weight gain, clinical trial, antipsychotic, metabolic syndrome, psychopharmacology, open label, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811973
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.